Article Per Year (5 Year)
p-Index From 2021 - 2026
0.817
P-Index
This Author published in this journals
All Journal Heart Science Journal
Bahar, Mokhamad Aswin
Unknown Affiliation
Health Professions Immunology & microbiology Medicine & Pharmacology

Published : 4 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 4 Documents
Search

 1 
Inflammatory cascade unveiled: Exploring complications and therapeutic strategies for post-myocardial infarction inflammation (A literature review) Bahar, Mokhamad Aswin; Prasetya, Indra
Heart Science Journal Vol. 5 No. 3 (2024): The Science and Art of Revascularization in Acute Coronary Syndrome
Publisher : Universitas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub/hsj.2024.005.03.4

Abstract

This comprehensive literature review delves into the inflammatory ramifications of myocardial infarction (MI), a global health concern with reported prevalences of 3.8% and 9.5% among those under and over 60 years, respectively. While the inflammatory cascade plays a crucial role in MI healing, its dysregulation can lead to complications. Recent advancements have unveiled intricate cellular and molecular pathways. The common post-MI complication of pericarditis poses diagnostic challenges due to symptom similarities with MI, requiring careful management, particularly in cases of Dressler’s syndrome. Promising therapeutic strategies, including anti-inflammatory approaches and ongoing drug development, are under exploration. Future research directions involve delving into unknown factors, identifying novel therapeutic targets, and validating emerging treatments in larger trials, emphasizing the imperative need for continued investigation into the inflammatory consequences of MI.
The role of GALNT and EGFR in vascular calcification: Study on pathophysiology and its implications in vascular therapy Bahar, Mokhamad Aswin; Rohman, Mohammad Saifur
Heart Science Journal Vol. 6 No. 2 (2025): The Complexity in the Management of Heart Rhythm Disorder
Publisher : Universitas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.hsj.2025.006.02.4

Abstract

Vascular calcification is a complex biomineralization process that occurs in arteries, primarily driven by the activity of vascular smooth muscle cells (VSMCs). This process involves the deposition of hydroxyapatite minerals in the arterial walls, particularly within the intima and media layers. Vascular calcification significantly increases the risk of cardiovascular diseases, including myocardial infarction, stroke, and heart failure. Understanding the role of GalNAc-transferase (GALNT) and the epidermal growth factor receptor (EGFR) in vascular calcification has advanced significantly. GALNT is involved in the regulation of glycosylation and affects various biochemical pathways, including insulin signaling and lipid metabolism. Variations in GALNT expression can influence the risk of vascular calcification, highlighting the crucial role of glycosylation in the pathogenesis of vascular calcification. On the other hand, EGFR contributes to vascular calcification by modulating the activity of tissue-nonspecific alkaline phosphatase (TNAP) and the formation of calcifying extracellular vesicles, as well as through the proliferation and migration of VSMCs. A deeper understanding of the roles of GALNT and EGFR provides new insights into the pathophysiological mechanisms of vascular calcification and opens up opportunities for the development of more effective therapies. This review aims to enhance scientific knowledge and provide a foundation for further research and the development of more targeted and personalized therapies in the prevention and treatment of vascular calcification.
Personalized assessment and management of patients with coexisting supraventricular tachycardia and coronary artery disease: A case series Bahar, Mokhamad Aswin; Rizal, Ardian
Heart Science Journal Vol. 7 No. 1 (2026): Accelerating Clinical Breakthroughs: The Journey from Molecular Discovery to Pa
Publisher : Universitas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.hsj.2026.007.01.23

Abstract

Background: Supraventricular tachycardia (SVT) and coronary artery disease (CAD) are common cardiovascular diseases that can exist simultaneously, complicating diagnosis and treatment. This case series aims to present clinical scenarios and management strategies in patients with both conditions, emphasizing the decision-making process between ablation and revascularization. Case Presentations: Three male patients, between 51 and 63 years old, presented with recurrent palpitations which sometimes accompanied by chest discomfort or exertional dyspnea. All patients had cardiovascular risk factors. Angiography revealed either multivessel CAD or a history of percutaneous coronary intervention (PCI). Electrocardiogram (ECG) showed different tachyarrhythmias which included atrioventricular nodal reentrant tachycardia (AVNRT), atrial tachycardia (AT), and Wolff-Parkinson-White (WPW) syndrome. The management strategies depended on the main clinical issue present. The treatment of patients with significant ischemia involved PCI with drug-eluting stents (DES) to achieve both symptom relief and rhythm stabilization. On the contrary, when arrhythmia was the main driver of symptoms, catheter ablation successfully eliminated the tachyarrhythmia and enhanced the quality of life. Conclusions: Adequate diagnosis of arrhythmia, its underlying mechanisms, substrates, and triggers by use of electrophysiological study is crucial for well-adapted, multidisciplinary selection of intervention—catheter ablation, PCI, or both—as key to clinical best results.
Comparison of decaffeinated green tea and green coffee with metformin and empagliflozin on the GALNT2 and GALNT3 mRNA expression in metabolic syndrome rats Bahar, Mokhamad Aswin; Rohman, Mohammad Saifur; Kurnianingsih, Novi
Heart Science Journal Vol. 7 No. 1 (2026): Accelerating Clinical Breakthroughs: The Journey from Molecular Discovery to Pa
Publisher : Universitas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.hsj.2026.007.01.7

Abstract

Background: Aberrant protein glycosylation mediated by the UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase (GALNT) family has been implicated in the pathogenesis of metabolic syndrome (MetS), yet the roles of GALNT2 and GALNT3 remain poorly characterized. Objective: This study aimed to evaluate the modulatory effects of decaffeinated green tea and green coffee on GALNT2 and GALNT3 mRNA expression in MetS rats, compared with standard therapies, metformin and empagliflozin. Methods: Twenty-five male Sprague Dawley (SD) rats were divided into five groups randomly: (1) MetS rats (METS), (2) MetS rats treated with 300 mg/kgBW decaffeinated green tea and 200 mg/kgBW decaffeinated green coffee (TKD), (3) MetS rats treated with 500 mg/kgBW metformin (MFN), (4) MetS rats treated with 30 mg/kgBW empagliflozin (EMPA), and (5) negative control (NC). The MetS model was induced using a high-fat, high-sucrose (HFHS) diet followed by streptozotocin injection (30 mg/kgBW). After 10 weeks, the treatment groups received interventions for 9 weeks. GALNT2 and GALNT3 mRNA expression was investigated using reverse transcription polymerase chain reaction (RT-PCR).. Result: TKD and MFN tended to decrease GALNT2 and increase GALNT3 mRNA expression, although the differences were not significant statistically compared to the METS group (p>0.05). EMPA decreased GALNT2 and increased GALNT3 mRNA expression significantly compared to the METS group (p<0.05). Conclusion: The significant effect of EMPA on GALNT2 and GALNT3 mRNA expression suggests its therapeutic potential in targeting glycosylation pathways in MetS. Although TKD and MFN exhibited similar trends with EMPA, the lack of statistical significance suggests the need for further study.
Co-Authors Indra Prasetya Kurnianingsih, Novi Mohammad Saifur Rohman Rizal, Ardian